Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0021345 (
infectious mononucleosis
)
3,358
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Acute
infectious mononucleosis
(AIM) is a widespread viral disease that mostly affects children. Development of AIM is accompanied by a change in the ratio of immune cells. This is provided by means of different biological processes including the regulation of apoptosis of naive T-cells. One of the potential regulators of apoptosis of T-lymphocytes is a
death receptor 3
(
DR3
). We have studied the role of
DR3
in the regulation of apoptosis of naive CD4
+
(nTh) and CD8
+
(nCTL) T-cells in healthy children and children with AIM. In healthy children as well as in children with AIM, the activation of
DR3
is accompanied by inhibition of apoptosis of nTh. In healthy children, the stimulation of
DR3
resulted in the increase in apoptosis of nCTL. On the contrary, in children with AIM, the level of apoptosis of nCTL decreased after
DR3
activation, which is a positive contribution to the antiviral immune response. In children with AIM, nCTL are characterized by reduced level of apoptosis as compared with healthy children. These results indicate that
DR3
can be involved in the reduction of sensitivity of nCTL to apoptosis in children with AIM.
...
PMID:DR3 regulation of apoptosis of naive T-lymphocytes in children with acute infectious mononucleosis. 2768 48